Congenital heart disease (CHD) is one of the most common birth defects, but the full extent of its genetic underpinnings has ...

Nucleus Genomics claims to give couples a picture of their combined risk for passing down hundreds of conditions to their ...

A pioneering screening trial, recently announced at the Bethesda Lyceum, aims to transform community health by providing ...

A licensing deal with Jiangsu Hengrui Pharmaceuticals puts Merck in a competitive race to develop a medicine that targets a ...

According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...

A test for abnormal fetal chromosomes can also detect maternal cancers—and physicians are struggling to incorporate that ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.

Me’s weekend bankruptcy filing has ignited concerns among consumers who provided the company with their genetic information, and reignited discussions on data privacy among policymakers and se | ...

23andMe cofounder and CEO Anne Wojcicki stepped down and the company filed for Chapter 11 bankruptcy protection, it said Sunday, capping a year-long saga that saw Wojcicki fail to convince her own ...

Robust Evidence of Disease Reversal in Severe Knock Out Mice Model Supports Tenaya’s Clinical Development Plan to Evaluate TN ...